Proteomics of endometrial cancer diagnosis, treatment, and prognosis

Simple item page
dc.contributor.authorMittal, P.
dc.contributor.authorKlingler-Hoffmann, M.
dc.contributor.authorArentz, G.
dc.contributor.authorZhang, C.
dc.contributor.authorKaur, G.
dc.contributor.authorOehler, M.
dc.contributor.authorHoffmann, P.
dc.date.issued2016
dc.description.abstractThis review discusses the current status of proteomics technology in endometrial cancer diagnosis, treatment and prognosis. The first part of this review focuses on recently identified biomarkers for endometrial cancer, their importance in clinical use as well as the proteomic methods used in their discovery. The second part highlights some of the emerging mass spectrometry based proteomic technologies that promise to contribute to a better understanding of endometrial cancer by comparing the abundance of hundreds or thousands of proteins simultaneously.
dc.description.statementofresponsibilityParul Mittal, Manuela Klingler-Hoffmann, Georgia Arentz, Chao Zhang, Gurjeet Kaur, Martin K. Oehler, and Peter Hoffmann
dc.identifier.citationProteomics - Clinical Applications, 2016; 10(3):217-229
dc.identifier.doi10.1002/prca.201500055
dc.identifier.issn1862-8346
dc.identifier.issn1862-8354
dc.identifier.orcidMittal, P. [0000-0003-0139-9757]
dc.identifier.orcidKlingler-Hoffmann, M. [0000-0003-2165-7813]
dc.identifier.orcidOehler, M. [0000-0002-2651-5913]
dc.identifier.urihttp://hdl.handle.net/2440/99849
dc.language.isoen
dc.publisherWilely
dc.rights© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
dc.source.urihttps://doi.org/10.1002/prca.201500055
dc.subjectBiomarker
dc.subjectEndometrial cancer
dc.titleProteomics of endometrial cancer diagnosis, treatment, and prognosis
dc.typeJournal article
pubs.publication-statusPublished

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_99849.pdf
Size:
1.03 MB
Format:
Adobe Portable Document Format
Description:
Accepted version
Download

Collections

Molecular and Biomedical Science publications